Inventor

BROOKS M. BOYD

Inventor

Overview

3→

Patents

2022–2023

Patent span

Human necessities

Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes25%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%

C07CAcyclic or carbocyclic compounds17%

C07DHeterocyclic compounds17%

A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for8%

A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation8%

PatentTitleYear

11,673,852Metabolism resistant fenfluramine analogs and methods of using the same2023 11,458,111Ketogenic diet compatible fenfluramine formulation2022 11,325,882Metabolism resistant fenfluramine analogs and methods of using the same2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to ZOGENIX INTERNATIONAL LTD (3)· patent assignee history

2022–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ZOGENIX INTERNATIONAL LTD	3	2022–2023

Locations

Location	Patents	Span
US	3	2022–2023